As China’s zero-tolerance approach to Covid-19 faces its stiffest test in the two-year-old pandemic, policymakers are moving to recalibrate the strategy to better protect the world’s largest population while balancing the costs.
Cover Story: China’s Covid Response Calibration
2022年03月21日 16:41
As omicron variants spur China’s worst flare-ups since 2020, policymakers move to tweak the largely successful Zero-Covid strategy
![]()
- China allows the use of rapid antigen tests to diagnose Covid-19 for the first time as a fast-spreading omicron outbreak challenges its Covid Zero playbook
[财新双语通产品，是为有双语需求读者专门订制的优惠产品， 按此可享超值优惠订阅。]
版面编辑：喻竹杨洋
图片推荐
视听推荐
编辑推荐
最新文章
- 22:51国联证券拟定增募资 全面收购民生证券
- 22:29东航物流净利跌超三成 跨境电商货增长迅速
- 22:10人事观察｜中国人民大学原副校长洪大用 ...
- 22:08神舟十八号成功发射 将在太空“养鱼”
- 21:58美国一季度GDP远逊预期 纳指开盘跌超2%
- 21:40涉数据产业知识产权案件数量逐年上升 超...
- 21:36小米汽车预计全年交付10万台 雷军称智...
- 21:08美制300公里射程导弹已投入乌克兰战场...
- 20:20被控受贿17年 云南高官崔茂虎案一审开庭
- 19:19商汤发布“日日新5.0”AI大模型 股...
京公网安备 11010502034662号 